首頁
U.S. Pharmacopeia

11月 2025U.S. Pharmacopeia的市場佔有率分析

Read answers to frequently asked questions about USP's rationale for proposed standards for elemental impurities.

健康 > 健康 - 其他

域名usp.org

成立年份1820

僱員1001 - 5000

年度營收$200M - $500M

U.S. Pharmacopeia

U.S. Pharmacopeia（包含公司地區）

usp.org

查看更多網站流量與參與度資訊

U.S. Pharmacopeia截至 11月 2025 的總收入為 200M - 500M

U.S. Pharmacopeia 熱門網域產生的總收入

U.S. Pharmacopeia 熱門網域 3 年內的總收入

U.S. Pharmacopeia 熱門網域的總收入

usp.org200M - 500M

透過銷售情報查看更多內容

U.S. Pharmacopeia的熱門網域總造訪量

了解U.S. Pharmacopeia市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

usp.org651.6K

透過銷售情報查看更多內容

U.S. Pharmacopeia的熱門網域平均造訪時長

分析U.S. Pharmacopeia參與度指標。

過去 3 個月平均造訪時長

子公司細目

usp.org00:01:16

透過銷售情報查看更多內容

U.S. Pharmacopeia的熱門網域平均頁面瀏覽量

了解U.S. Pharmacopeia如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

usp.org2.53

透過銷售情報查看更多內容

U.S. Pharmacopeia按網域劃分的熱門競爭對手

11月 2025的熱門類似網站，依相似度排名

uspnf.com公司名U.S. Pharmacopeia僱員1001 - 5000總部美國, 馬里蘭, Frederick年度營收$200M - $500M訪問總量183.9K健康 > 生物技術和製藥

使用的熱門技術U.S. Pharmacopeia

这些是U.S. Pharmacopeia顶级域名使用的行业网站技术

付費廣告 (14)

Google Adsense

轉換與分析 (13)

Google Analytics

社群 (8)

Google+ Platform

市場行銷 (7)

Google Marketing Platform

更多技術

15

檢視所有

新聞與訊號來自U.S. Pharmacopeia

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞United States Pharmacopeia attends event The Vape Shop.At The Vape Shop, only USP and EP grade propylene glycol is used across all blends, including a natural e-liquid range.

新聞Bio-Techne partnered with United States Pharmacopeia on Jun 24th '25.MINNEAPOLIS, June 24, 2025 /PRNewswire/ - Bio-Techne Corporation (NASDAQ: TECH) today announced a distribution agreement with the U.S. Pharmacopeia (USP) that enables the Company to sell USP monoclonal antibody (mAb) and recombinant adeno-associated virus (AAV) reference standards with its analytical solutions, including the Maurice system, to support monoclonal antibody and gene therapy development around the world.

新聞Meadows left United States Pharmacopeia as Senior Technical Advisor for Product Supply Management and Chemistry Manufacturing and Controls on Dec 31st '24.With more than two decades of experience in the pharmaceuticals, medical devices, and chemical industries, Meadows joins CHPA from U.S. Pharmacopeia (USP), where he most recently served as the Senior Technical Advisor for Product Supply Management and Chemistry Manufacturing and Controls (CMC).